コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by (18)F-FDG accumulated in tumors to induce photoimmunotherapy.
2 without compromising therapeutic effects of photoimmunotherapy.
3 ial histologic analyses were conducted after photoimmunotherapy.
4 as reduced by more than 99% within 1 h after photoimmunotherapy.
5 immunoconjugate uptake as a way of enhancing photoimmunotherapy.
7 one of tumors changed size within 24 h after photoimmunotherapy, although diffuse necrosis was observ
9 ultiepitope targeting enhances HER2-targeted photoimmunotherapy and maintains a high degree of specif
10 eight of the tumors in the mice treated with photoimmunotherapy, and the median survival increased fr
11 or monitoring the acute cytotoxic effects of photoimmunotherapy before the tumor begins to shrink, we
12 cal assessment of the therapeutic effects of photoimmunotherapy earlier than anatomic methods that re
14 ese concepts of "tumor-targeted, activatable photoimmunotherapy" in a mouse model of peritoneal carci
20 uggest cationic PICs may have advantages for photoimmunotherapy of disseminated intracavity cancer fo
22 ugate for combined fluorescent detection and photoimmunotherapy (PIT) of CD44 expressing cells in TNB
23 w type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific ph
25 y (mAb)-based, highly specific phototherapy (photoimmunotherapy; PIT) that uses a near infrared (NIR)
26 Consequently, it seems that multitargeted photoimmunotherapy should also be useful against cancers
30 The uptake of (18)F-FDG in the tumor after photoimmunotherapy was evaluated in cellular uptake stud
34 ecently developed a cancer-specific therapy, photoimmunotherapy, which uses an antibody-IR700 (photot
37 more effective than single-epitope targeted photoimmunotherapy with a single anti-HER2 photosensitiz
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。